Cargando…

Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood

There is mounting evidence that the gut microbiota plays an important role in the pathogenesis of inflammatory bowel disease (IBD). For the past decade, high throughput sequencing-based gut microbiome research has identified characteristic shifts in the composition of the intestinal microbiota in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eindor-Abarbanel, Adi, Healey, Genelle R., Jacobson, Kevan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622771/ https://www.ncbi.nlm.nih.gov/pubmed/34830388 http://dx.doi.org/10.3390/ijms222212506

Ejemplares similares

Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
por: Healey, Genelle R., et al.
Publicado: (2020)

Prebiotic Enriched Exclusive Enteral Nutrition Suppresses Colitis via Gut Microbiome Modulation and Expansion of Anti-inflammatory T Cells in a Mouse Model of Colitis
por: Lunken, Genelle R., et al.
Publicado: (2021)

User testing to modify the MyHealthyGut digital health application for inflammatory bowel disease
por: Erlich, Madeline, et al.
Publicado: (2023)

The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel
por: Naftali, Timna, et al.
Publicado: (2018)

Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
por: Broide, Efrat, et al.
Publicado: (2020)

A28 RESPONSE RATE OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PATIENTS TO ANTI-TNF TREATMENT IS HIGHER THAN PREVIOUSLY REPORTED, BUT HIGHER DOSING IS REQUIRED-A LARGE TERTIARY SINGLE CENTER EXPERIENCE
por: Eindor, A, et al.
Publicado: (2022)

Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review
por: Lawrence, Sally J., et al.
Publicado: (2017)

Lymphoid follicles in children with Helicobacter pylori-negative gastritis
por: Broide, Efrat, et al.
Publicado: (2017)

Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease
por: Michaux, Mielle, et al.
Publicado: (2023)

Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease
por: Olbjørn, Christine, et al.
Publicado: (2022)

Vitamin D, the gut microbiome and inflammatory bowel disease
por: Tabatabaeizadeh, Seyed-Amir, et al.
Publicado: (2018)

Dynamics of metatranscription in the inflammatory bowel disease gut microbiome
por: Schirmer, Melanie, et al.
Publicado: (2018)

Dynamics of the human gut microbiome in Inflammatory Bowel Disease
por: Halfvarson, Jonas, et al.
Publicado: (2017)

Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
por: Gubatan, John, et al.
Publicado: (2021)

Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases
por: Elzayat, Hala, et al.
Publicado: (2023)

High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease
por: Rodin, Isaac, et al.
Publicado: (2019)

Gut microbiome structure and metabolic activity in inflammatory bowel disease
por: Franzosa, Eric A., et al.
Publicado: (2018)

Interactions between Medications and the Gut Microbiome in Inflammatory Bowel Disease
por: Eckenberger, Julia, et al.
Publicado: (2022)

The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis
por: Zheng, Jiaying, et al.
Publicado: (2022)

Changing Incidence of Inflammatory Bowel Disease: Environmental Influences and Lessons Learnt from the South Asian Population
por: Foster, Alice, et al.
Publicado: (2013)

Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
por: O’Reilly, Catherine, et al.
Publicado: (2023)

Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease
por: Wellington, Vivian Naa Amua, et al.
Publicado: (2021)

Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer
por: Gubatan, John, et al.
Publicado: (2022)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
por: Kapoor, Akshay, et al.
Publicado: (2021)

Propionate Fermentative Genes of the Gut Microbiome Decrease in Inflammatory Bowel Disease
por: Medina, Juan Manuel, et al.
Publicado: (2021)

The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease
por: Guzzo, Gina L, et al.
Publicado: (2022)

The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy
por: Fernandes, Darren, et al.
Publicado: (2022)

Inflammatory bowel disease biomarkers revealed by the human gut microbiome network
por: Hu, Mirko, et al.
Publicado: (2023)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood
por: Chung, Wei-Sheng, et al.
Publicado: (2021)

Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
por: Hart, Lara, et al.
Publicado: (2021)

Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders
por: Lee, Hyo Jeong, et al.
Publicado: (2017)

The gut microbiome and irritable bowel syndrome
por: Menees, Stacy, et al.
Publicado: (2018)

Metabolic Phenotypes as Potential Biomarkers for Linking Gut Microbiome With Inflammatory Bowel Diseases
por: Iablokov, Stanislav N., et al.
Publicado: (2021)

Linking Inflammatory Bowel Disease Symptoms to Changes in the Gut Microbiome Structure and Function
por: Hassouneh, Sayf Al-Deen, et al.
Publicado: (2021)

Gut microbiome as a potential biomarker of cancer risk in inflammatory bowel disease
por: Jones, Ryan Lane
Publicado: (2022)

Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study
por: Olendzki, Barbara, et al.
Publicado: (2022)

Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance
por: Fiorindi, Camilla, et al.
Publicado: (2022)

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
por: Yu, Si, et al.
Publicado: (2023)

Gut Microbiome Modulation for Preventing and Treating Pediatric Food Allergies
por: Di Costanzo, Margherita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8o9h8gnf6comk67fd864ukd6sn